search

Active clinical trials for "Skin Diseases"

Results 321-330 of 402

Efficacy Evaluation of Triple up® Collagen Drink on Skin Condition

Skin Condition

To assess Triple up® Collagen Drink on skin condition improvement

Completed8 enrollment criteria

Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies...

CarcinomaNon-Small-Cell Lung2 more

It is important for patients treated with anti-EGFR therapies to get access to cosmetic options to preserve their skin condition during treatment. Anti-EGFR therapies are known to fragilize epidermis and to provoke rashes; which often lead to treatment discontinuation. The aim of this study is to demonstrate that the Onco-Rash cream is able to preserve skin condition without side effects. Decreasing skin toxicity is expected to improve patients' life and facilitate treatment follow-up.

Unknown status20 enrollment criteria

Dalbavancin in Real Clinical Practice in Spain

Skin DiseasesBacterial2 more

The aim of this study is to describe the real clinical use of Dalbavancin in Spain between January 2018 and December 2019.

Completed5 enrollment criteria

Efficacy Testing of Collagen Peptide Drink

Skin Condition

To assess Collagen Peptide Drink on skin condition improvement

Completed8 enrollment criteria

Efficacy Testing of Collagen and Zhuyin Drinks

Skin Condition

To assess collagen and zhuyin drink on skin & body condition improvement

Completed8 enrollment criteria

Efficacy and Safety of Kinetin 0.1% for Treatment of Skin Photoaging

Cutaneous Photoaging

The purpose of the study is to evaluate the change in the severity and clinical signs of skin photoaging among Filipino patients using Kinerase cream (Kinetin 0.1%). This study will recruit 132 subjects from dermatological clinics in a tertiary hospital in the Philippines for a period of 3 months (12 weeks). Changes in severity will be documented using physician evaluation, self-evaluation, and through VISIA complexion analysis system.

Completed14 enrollment criteria

Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness...

Skin Graft DisorderDisorder of Skin Donor Site1 more

Split-thickness skin grafting remains fundamental treatment of patients with deep burns and other traumatic injuries. However, the split-thickness skin graft (STSG) donor site dressing has been controversial until now. Our study here aimed to assess patient comfort and wound-healing efficacy with the application of thin split-thickness grafting on STSG donor sites.

Completed2 enrollment criteria

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists...

EczemaDermatitis13 more

The purpose of this study is to investigate the differences in the quality of life of patients and caregivers who are treated by general pediatricians versus pediatric dermatologists for eczema (atopic dermatitis or AD).

Completed8 enrollment criteria

Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of...

Papulosquamous Skin Disease

Psoriasis is a multisystem disease predominately manifested as chronic inflammation of the skin and characterized by scaly, erythematous patches, papules and plaques, which are often pruritic. As chronic disease, psoriasis waxes and wanes throughout patient life time. The disease course is modified with initiation and cessation of treatment, and spontaneous remission is rare. Clinically lesions can be distributed in any part of the body, this leads to impaired consequences on the perception of body image, social relations and in general on quality of life.

Unknown status3 enrollment criteria

Post-Authorization Study Evaluating Safety Of Tigecycline

Intra-Abdominal InfectionsSkin Disease2 more

This is a study to evaluate the safety of tigecycline in patients with complicated intra-abdominal infections (cIAI) and complicated skin and soft tissue infections (cSSTI) under real practice in the usual hospital setting and patients' conditions, in order to assess the "real incidence" of adverse events related with tigecycline in these patients.

Completed9 enrollment criteria
1...323334...41

Need Help? Contact our team!


We'll reach out to this number within 24 hrs